Inactivation of P450 2B1 by 7-Ethynylcoumarin
Chem. Res. Toxicol., Vol. 13, No. 4, 2000 269
of human CYP2C9 for diclofenac and ibuprofen. Arch. Biochem.
Biophys. 357, 240-248.
5) Vaz, A. D., McGinnity, D. F., and Coon, M. J . (1998) Epoxidation
of olefins by cytochrome P450: evidence from site-specific muta-
genesis for hydroperoxo-iron as the electrophilic oxidant. Proc.
Natl. Acad. Sci. U.S.A. 95, 3555-3560.
6) Ibeanu, G. C., Blaisdell, J ., Ferguson, R. J ., Ghanayem, B. J .,
Brosen, K., Benhamou, S., Bouchardy, C., Wilkinson, G. R., Dayer,
P., and Goldstein, J . A. (1999) A novel transversion in the intron
cytochrome P450s 2B1, 2B4, 2B6 and 2B11 by arylalkynes. Drug
Metab. Dispos. 25, 1242-1248.
(
(24) Koenigs, L. L., Peter, R. M., Hunter, A. P., Haining, R. L., Rettie,
A. E., Freidberg, T., Pritchard, M. P., Shou, M., Rushmore, T.
H., and Trager, W. F. (1999) Electrospray ionization mass
spectrometric analysis of intact cytochrome P450: identification
of tienilic acid adducts to P450 2C9. Biochemistry 38, 2312-2319.
(25) He, K., Iyer, K. R., Hayes, R. N., Sinz, M. W., Woolf, T. F., and
Hollenberg, P. F. (1998) Inactivation of cytochrome P450 3A4 by
bergamottin, a component of grapefruit juice. Chem. Res. Toxicol.
11, 252-259.
(26) Cai, Y., Baer-Dubowska, W., Ashwood-Smith, M. J ., Ceska, O.,
Tachibana, S., and DiGiovanni, J . (1996) Mechanism-based
inactivation of hepatic ethoxyresorufin O-dealkylation activity by
naturally occurring coumarins. Chem. Res. Toxicol. 9, 729-736.
(27) Letterton, P., Descatoire, V., Larrey, D., Tinel, M., Geneve, J .,
and Pessayre, D. (1986) Inactivation and induction of cytochrome
P450 by various psoralen derivatives in rats. J . Pharmacol. Exp.
Ther. 238, 685-692.
(28) Tinel, M., Belghiti, J ., Descatoire, V., Amouyal, G., Letterton, P.,
Geneve, J ., Larrey, D., and Pessayre, D. (1987) Inactivation of
human liver cytochrome P-450 by the drug methoxsalen and other
psoralen derivatives. Biochem. Pharmacol. 36, 951-955.
(29) Koenigs, L. L., and Trager, W. F. (1998) Mechanism-based
inactivation of P450 2A6 by furanocoumarins. Biochemistry 37,
10047-10061.
(
5
donor splice junction of CYP2C19 and a sequence polymorphism
in exon 3 contribute to the poor metabolizer phenotype for the
anticonvulsant drug S-mephenytoin. J . Pharmacol. Exp. Ther.
2
90, 635-640.
(
7) Biagini, C. P., Philpot, R. M., and Celier, C. M. (1999) Nonsub-
strate recognition site residues involved in testosterone hydroxyl-
ation by cytochrome CYP 2C11. Arch. Biochem. Biophys. 361,
3
09-314.
(
8) Kidd, R. S., Straughn, A. B., Meyer, M. C., Blaisdell, J ., Goldstein,
J . A., and Dalton, J . T. (1999) Pharmacokinetics of chlorphenir-
amine, phenytoin, glipixide and nifedipine in an individual
homozygous for the CYP2C9*3 allelle. Pharmacogenetics 9, 71-
8
0.
(
9) Dacou-Voutekakis, C., and Dracopoulou, M. (1999) High incidence
of molecular defects of the CYP21 gene in patients with premature
adrenarche. J . Clin. Endocrinol. Metab. 84, 1570-1574.
10) Lewis, D. F., and Lee-Robichaud, P. (1998) Molecular modelling
of steroidogenic cytochromes P450 from families CYP11, CYP17,
CYP19 and CYP21 based on the CYP102 crystal structure. J .
Steroid Biochem. Mol. Biol. 66, 217-233.
11) Lewis, D. F., Lake, B. G., Dickens, M., Eddershaw, P. J ., Tarbit,
M. H., and Goldfarb, P. S. (1999) Molecular modelling of CYP2B6,
the human CYP2B isoform, by homology with the substrate-bound
CYP102 crystal structure: evaluation of CYP2B6 substrate
(
(30) Cai, Y., Bennett, D., Nair, R. V., Ceska, O., Ashwood-Smith, M.
J ., and DiGiovanni, J . (1993) Inhibition and inactivation of murine
hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally
occurring coumarins. Chem. Res. Toxicol. 6, 872-879.
(31) van Iersel, M. L., Henderson, C. J ., Walters, D. G., Price, R. J .,
(
1
4
Wolf, C. R., and Lake, B. G. (1994) Metabolism of [3- C]coumarin
by human liver microsomes. Xenobiotica 24, 795-803.
(32) Fentem, J . H., and Fry, J . R. (1992) Metabolism of coumarin by
rat, gerbil and human liver microsomes. Xenobiotica 22, 357-
367.
characteristics, the cytochrome b
5
binding site and comparisons
with CYP2B1 and CYP2B4. Xenobiotica 29, 361-393.
12) Haining, R. L., J ones, J . P., Henne, K. R., Fisher, M. B., Koop, D.
R., Trager, W. F., and Rettie, A. E. (1999) Enzymatic determi-
nants of the substrate specificity of CYP2C9: role of B′-C loop
residues in providing the pi-stacking anchor for warfarin binding.
Biochemistry 38, 3285-3292.
13) Wang, H., Dick, R., Yin, H., Licad-Coles, E., Kroetz, D. L., Sklarz,
G., Harlow, G., Halpert, J . R., and Correia, M. A. (1998)
Structure-function relationships of human liver cytochromes
P450 3A: aflatoxin B1 metabolism as a probe. Biochemistry 37,
(
(
(
(33) Nims, R. W., and Lubet, R. A. (1996) The CYP2B subfamily.
In Cytochromes P450: Metabolic and Toxicological Aspects
(Ioannides, C., Ed.) pp 135-160, CRC Press, New York.
(34) Ullrich, V., and Weber, P. (1972) The O-dealkylation of 7-ethoxy-
coumarin by liver microsomes. A direct fluorometric test. Hoppe-
Seyler’s Z. Physiol. Chem. 353, 1171-1177.
(35) Buters, J . T., Schiller, C. D., and Chou, R. C. (1993) A highly
sensitive tool for the assay of cytochrome P450 enzyme activity
in rat, dog and man. Biochem. Pharmacol. 46, 1577-1584.
(36) Saito, T., and Strobel, H. W. (1981) Purification to homogeneity
and characterization of a form of cytochrome P450 with a high
specificity for benzopyrene from â-naphthoflavone-pretreated rat
liver microsomes. J . Biol. Chem. 256, 984-988.
(37) Rettie, A. E., Eddy, A. C., Heimark, L. D., Gibaldi, M., and Trager,
W. F. (1989) Characteristics of warfarin hydroxylation catalyzed
by human liver microsomes. Drug Metab. Dispos. 17, 265-270.
(38) Waxman, D. J ., and Walsh, C. (1982) Phenobarbital-induced rat
liver cytochrome P-450. Purification and characterization of 2
closely related isozymic forms. J . Biol. Chem. 257, 10446-10457.
(39) Hanna, I. H., Teiber, J . F., Kokones, K. L., and Hollenberg, P. F.
(1998) Role of alanine at position 363 of cytochrome P450 2B2 in
influencing the NADPH- and hydroperoxide-supported activities.
Arch. Biochem. Biophys. 350, 324-332.
(40) Estabrook, R. W., Peterson, J ., Baron, J ., and Hildebrandt, A.
(1972) The spectrophotometric measurement of turbid suspen-
sions of cytochromes associated with drug metabolism. Methods
Pharmacol. 2, 303-350.
1
2536-12545.
14) J ung, F., Griffin, K. J ., Song, W., Richardson, T. H., Yang, M.,
and J ohnson, E. F. (1998) Identification of amino acid substitu-
tions that confer a high affinity for sulfaphenazole binding and a
high catalytic efficiency for warfarin metabolism to P450 2C19.
Biochemistry 37, 16270-16279.
15) Zimmer, T., Scheller, U., Tagaki, M., and Schunk, W. H. (1998)
Mutual conversion of fatty acid substrate specificity by a single
amino acid exchange at position 527 in P-450Cm2 and P-450Alk3A.
Eur. J . Biochem. 256, 398-403.
(
(
(
16) Roberts, E. S., Lin, H.-L., Crowley, J . R., Vuletich, J . L., Osawa,
Y., and Hollenberg, P. F. (1998) Peroxynitrite-mediated nitration
of tyrosine and inactivation of the catalytic activity of cytochrome
P450 2B1. Chem. Res. Toxicol. 11, 1067-1074.
17) He, K., Falick, A. M., Chen, B., Nilsson, F., and Correia, M. A.
(1996) Identification of the heme adduct and an active site peptide
modified during mechanism-based inactivation of rat liver cyto-
chrome P450 2B1 by secobarbital. Chem. Res. Toxicol. 9, 614-
6
22.
(
18) Roberts, E. S., Hopkins, N. E., Alworth, W. L., and Hollenberg,
P. F. (1993) Mechanism-based inactivation of cytochrome P450
(41) Silverman, R. B. (1988) Mechanism-based enzyme inactivation.
In Chemistry and Enzymology, Vol. I, pp 3-30, CRC Press, Boca
Raton, FL.
2
B1 by 2-ethynylnaphthalene: identification of an active site
peptide. Chem. Res. Toxicol. 6, 470-479.
(42) Maenpaa, J ., Sigusch, H., Raunio, H., Syngelma, T., Vuorela, P.,
Vuorela, H., and Pelkonen, O. (1993) Differential inhibition of
coumarin 7-hydroxylase activity in mouse and human liver
microsomes. Biochem. Pharmacol. 45, 1035-1042.
(43) Yamazaki, H., Tanaka, M., and Shimada, T. (1999) Highly
sensitive high-performance liquid chromatographic assay for
coumarin 7-hydroxylation and 7-ethoxycoumarin O-deethylation
by human liver cytochrome P450 enzymes. J . Chromatogr. B 721,
13-19.
(44) Ortiz de Montellano, P. R., and Correia, M. A. (1995) Inhibition
of cytochrome P450 enzymes. In Cytochrome P450: Structure,
Mechanism and Biochemistry (Ortiz de Montellano, P. R., Ed.)
pp 305-364, Plenum Press, New York.
(45) J ohnston, J . O., Wright, C. L., Holbert, G. W., and Benson, H. D.
(1990) Enzyme inactivation by potential metabolites of an aro-
matase-activated inhibitor (MDL 18,962). J . Enzyme Inhib. 4,
137-142.
(
19) Roberts, E. S., Hopkins, N. E., Zaluzec, E. J ., Gage, D. A., Alworth,
W. L., and Hollenberg, P. F. (1995) Mechanism-based inactivation
of cytochrome P450 2B1 by 9-ethynylphenanthrene. Arch. Bio-
chem. Biophys. 323, 295-302.
20) Halpert, J . (1981) Covalent modification of lysine during the
suicide inactivation of rat liver cytochrome P-450 by chloram-
phenicol. Mol. Pharmacol. 21, 166-172.
21) Kent, U. M., Bend, J . R., Chamberlin, B. A., Gage, D. A., and
Hollenberg, P. F. (1997) Mechanism-based inactivation of cyto-
chrome P450 2B1 by N-benzyl-1-aminobenzotriazole. Chem. Res.
Toxicol. 10, 600-608.
22) Kent, U. M., Yanev, S., and Hollenberg, P. F. (1999) Mechanism-
based inactivation of cytochromes P450 2B1 and P450 2B6 by
n-propylxanthate. Chem. Res. Toxicol. 12, 317-322.
(
(
(
(
23) Roberts, E. S., Hopkins, N. E., Foroozesh, M., Alworth, W. L.,
Halpert, J . R., and Hollenberg, P. F. (1997) Inactivation of